Biotech Values

[dewophile]

HCV drugs in development

based on clinicaltrials.gov BMS-790052 is now in phase II (the single dose ascending trial - listed as a phase 2 but is really a 1b - is completed, and the phase II in combination with SOC is now enrolling). one would think the 1b data would be presented soon unless BMY is holding back for competitive reasons (BMY seems to be cagey with their HCV development program - they have 2 other drugs in 1b the targets of which i still think are not disclosed - BMS-791325 and BMS-650032)

also i vaguely recall ABT had a drug moving under the radar into phase 2 for an undisclosed target, but now I can't find the trial listed